XML 102 R91.htm IDEA: XBRL DOCUMENT v3.6.0.2
Restatement of Previously Reported Consolidated Financial Statements - Restated Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
May 18, 2016
Feb. 16, 2016
Oct. 30, 2015
Aug. 17, 2015
May 18, 2015
Feb. 17, 2015
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:                    
Net income             $ (2,384) $ (14,998) $ (9,110) $ 24,972
Adjustments to reconcile net income (loss) to cash provided by operating activities:                    
Depreciation and amortization             51,896 57,539 105,823 114,552
Long-lived asset impairment             13,808 9,510 23,668 17,663
Amortization of deferred financing costs                 2,719 3,127
(Income) loss from discontinued operations, net of tax             26 19,328 26 (14,460)
Amortization of debt discount                 613 576
Provision for doubtful accounts                 2,354 322
Gain on sale of property, plant and equipment                 (23) (1,845)
Equity in income of non-consolidated affiliates                 635 0
Amortization of terminated interest rate swaps                 142 1,884
Interest rate swaps                 649 (7)
Loss on remeasurement of intercompany balances                   0
Stock-based compensation expense                 5,203 5,006
Non-cash restructuring charges                 1,187 1,000
Deferred income tax provision                 (8,200) (5,634)
Changes in assets and liabilities, net of acquisitions:                    
Accounts receivable and notes                 26,368 10,906
Inventory                 10,611 (1,717)
Costs and estimated earnings versus billings on uncompleted contracts                   0
Other current assets                 5,726 (657)
Accounts payable and other liabilities                 (30,753) (9,226)
Deferred revenue                 (550) (55)
Other                 (101) 5,083
Net cash provided by continuing operations                 136,987 151,490
Net cash provided by (used in) discontinued operations                 (67) 35,822
Net cash provided by operating activities                 136,920 187,312
Cash flows from investing activities:                    
Capital expenditures                 (72,200) (160,948)
Proceeds from sale of property, plant and equipment                 16,948 14,136
Return of investments in non-consolidated affiliates                   0
Proceeds received from settlement of note receivable                   0
Net cash used in continuing operations                 (69,031) (146,812)
Net cash used in discontinued operations                 0 (56,035)
Net cash used in investing activities                 (69,031) (202,847)
Cash flows from financing activities:                    
Proceeds from borrowings of long-term debt                 259,000 765,500
Repayments of long-term debt                 (275,000) (703,000)
Payments for debt issuance costs                 (2,112) (1,311)
Payments for settlement of interest rate swaps that include financing elements                 (1,590) (1,877)
Net proceeds from the sale of Partnership units                 0 1,268
Proceeds from stock options exercised                 0 1,005
Proceeds from stock issued pursuant to our employee stock purchase plan                 0 910
Purchases of treasury stock                 (749) (3,736)
Dividends to Archrock stockholders $ (6,700) $ (13,100) $ (10,400) $ (10,500) $ (10,400) $ (10,300)     (19,763) (20,743)
Stock-based compensation excess tax benefit                 116 1,580
Distributions to noncontrolling partners in the Partnership                 (31,183) (40,491)
Net cash used in continuing operations                 (41,619) (895)
Net cash provided by discontinued operations                 0 799
Net cash used in continuing operations                 (41,619) (96)
Effect of exchange rate changes on cash and cash equivalents                 0 (783)
Net increase (decrease) in cash and cash equivalents                 26,270 (16,414)
Less: Net decrease in cash and cash equivalents - discontinued operations                 0 (16,312)
Cash and cash equivalents at beginning of period                 1,563 378
Cash and cash equivalents at end of period             $ 27,833 276 $ 27,833 276
As Previously Reported                    
Cash flows from operating activities:                    
Net income               7,789   48,874
Adjustments to reconcile net income (loss) to cash provided by operating activities:                    
Depreciation and amortization               94,325   190,133
Long-lived asset impairment               15,420   28,152
Amortization of deferred financing costs                   3,127
(Income) loss from discontinued operations, net of tax               (254)   (18,967)
Amortization of debt discount                   576
Provision for doubtful accounts                   1,496
Gain on sale of property, plant and equipment                   (2,891)
Equity in income of non-consolidated affiliates                   (10,068)
Amortization of terminated interest rate swaps                   1,884
Interest rate swaps                   (7)
Loss on remeasurement of intercompany balances                   7,999
Stock-based compensation expense                   9,722
Non-cash restructuring charges                   0
Deferred income tax provision                   (13,234)
Changes in assets and liabilities, net of acquisitions:                    
Accounts receivable and notes                   51,147
Inventory                   2,595
Costs and estimated earnings versus billings on uncompleted contracts                   (22,438)
Other current assets                   (6,945)
Accounts payable and other liabilities                   (73,079)
Deferred revenue                   (2,986)
Other                   (9,129)
Net cash provided by continuing operations                   185,961
Net cash provided by (used in) discontinued operations                   1,351
Net cash provided by operating activities                   187,312
Cash flows from investing activities:                    
Capital expenditures                   (254,180)
Proceeds from sale of property, plant and equipment                   19,348
Return of investments in non-consolidated affiliates                   (10,068)
Proceeds received from settlement of note receivable                   5,357
Net cash used in continuing operations                   (219,407)
Net cash used in discontinued operations                   16,560
Net cash used in investing activities                   (202,847)
Cash flows from financing activities:                    
Proceeds from borrowings of long-term debt                   765,500
Repayments of long-term debt                   (703,000)
Payments for debt issuance costs                   (1,311)
Payments for settlement of interest rate swaps that include financing elements                   (1,877)
Net proceeds from the sale of Partnership units                   1,268
Proceeds from stock options exercised                   1,005
Proceeds from stock issued pursuant to our employee stock purchase plan                   910
Purchases of treasury stock                   (3,736)
Dividends to Archrock stockholders                   (20,743)
Stock-based compensation excess tax benefit                   2,379
Distributions to noncontrolling partners in the Partnership                   (40,491)
Net cash used in continuing operations                   (96)
Net cash provided by discontinued operations                   0
Net cash used in continuing operations                   (96)
Effect of exchange rate changes on cash and cash equivalents                   (783)
Net increase (decrease) in cash and cash equivalents                   (16,414)
Less: Net decrease in cash and cash equivalents - discontinued operations                   0
Cash and cash equivalents at beginning of period                   39,739
Cash and cash equivalents at end of period               23,325   23,325
Restatement Adjustments                    
Cash flows from operating activities:                    
Net income               (22,787)   (23,902)
Adjustments to reconcile net income (loss) to cash provided by operating activities:                    
Depreciation and amortization               97   194
Long-lived asset impairment               0   0
Amortization of deferred financing costs                   0
(Income) loss from discontinued operations, net of tax               0   0
Amortization of debt discount                   0
Provision for doubtful accounts                   0
Gain on sale of property, plant and equipment                   0
Equity in income of non-consolidated affiliates                   0
Amortization of terminated interest rate swaps                   0
Interest rate swaps                   0
Loss on remeasurement of intercompany balances                   0
Stock-based compensation expense                   0
Non-cash restructuring charges                   0
Deferred income tax provision                   1,889
Changes in assets and liabilities, net of acquisitions:                    
Accounts receivable and notes                   2,038
Inventory                   0
Costs and estimated earnings versus billings on uncompleted contracts                   10,238
Other current assets                   (37)
Accounts payable and other liabilities                   10,490
Deferred revenue                   0
Other                   (910)
Net cash provided by continuing operations                   0
Net cash provided by (used in) discontinued operations                   0
Net cash provided by operating activities                   0
Cash flows from investing activities:                    
Capital expenditures                   0
Proceeds from sale of property, plant and equipment                   0
Return of investments in non-consolidated affiliates                   0
Net cash used in continuing operations                   0
Net cash used in discontinued operations                   0
Net cash used in investing activities                   0
Cash flows from financing activities:                    
Proceeds from borrowings of long-term debt                   0
Repayments of long-term debt                   0
Payments for debt issuance costs                   0
Payments for settlement of interest rate swaps that include financing elements                   0
Proceeds from stock options exercised                   0
Proceeds from stock issued pursuant to our employee stock purchase plan                   0
Purchases of treasury stock                   0
Dividends to Archrock stockholders                   0
Stock-based compensation excess tax benefit                   0
Distributions to noncontrolling partners in the Partnership                   0
Net cash used in continuing operations                   0
Net cash provided by discontinued operations                   0
Net cash used in continuing operations                   0
Effect of exchange rate changes on cash and cash equivalents                   0
Net increase (decrease) in cash and cash equivalents                   0
Less: Net decrease in cash and cash equivalents - discontinued operations                   0
Cash and cash equivalents at beginning of period                   0
Cash and cash equivalents at end of period               0   0
Restatement Adjustments | Discontinued Operations                    
Cash flows from operating activities:                    
Net income               0   0
Adjustments to reconcile net income (loss) to cash provided by operating activities:                    
Depreciation and amortization               (36,883)   (75,775)
Long-lived asset impairment               (5,910)   (10,489)
Amortization of deferred financing costs                   0
(Income) loss from discontinued operations, net of tax               19,582   4,507
Amortization of debt discount                   0
Provision for doubtful accounts                   (1,174)
Gain on sale of property, plant and equipment                   1,046
Equity in income of non-consolidated affiliates                   10,068
Amortization of terminated interest rate swaps                   0
Interest rate swaps                   0
Loss on remeasurement of intercompany balances                   (7,999)
Stock-based compensation expense                   (4,716)
Non-cash restructuring charges                   1,000
Deferred income tax provision                   5,711
Changes in assets and liabilities, net of acquisitions:                    
Accounts receivable and notes                   (42,279)
Inventory                   (4,312)
Costs and estimated earnings versus billings on uncompleted contracts                   12,200
Other current assets                   6,325
Accounts payable and other liabilities                   53,363
Deferred revenue                   2,931
Other                   15,122
Net cash provided by continuing operations                   (34,471)
Net cash provided by (used in) discontinued operations                   34,471
Net cash provided by operating activities                   0
Cash flows from investing activities:                    
Capital expenditures                   93,232
Proceeds from sale of property, plant and equipment                   (5,212)
Return of investments in non-consolidated affiliates                   10,068
Proceeds received from settlement of note receivable                   (5,357)
Net cash used in continuing operations                   72,595
Net cash used in discontinued operations                   (72,595)
Net cash used in investing activities                   0
Cash flows from financing activities:                    
Proceeds from borrowings of long-term debt                   0
Repayments of long-term debt                   0
Payments for debt issuance costs                   0
Payments for settlement of interest rate swaps that include financing elements                   0
Proceeds from stock options exercised                   0
Proceeds from stock issued pursuant to our employee stock purchase plan                   0
Purchases of treasury stock                   0
Dividends to Archrock stockholders                   0
Stock-based compensation excess tax benefit                   (799)
Distributions to noncontrolling partners in the Partnership                   0
Net cash used in continuing operations                   (799)
Net cash provided by discontinued operations                   799
Net cash used in continuing operations                   0
Effect of exchange rate changes on cash and cash equivalents                   0
Net increase (decrease) in cash and cash equivalents                   0
Less: Net decrease in cash and cash equivalents - discontinued operations                   (16,312)
Cash and cash equivalents at beginning of period                   (39,361)
Cash and cash equivalents at end of period               $ (23,049)   $ (23,049)